Skip to main content
Top
Published in: Comparative Clinical Pathology 3/2018

01-05-2018 | Original Article

Detecting endomysial and tissue transglutaminase antibodies in patients with giardiasis

Authors: Fateme Hajialiani, Fatemeh Tabatabaie, Lame Akhlaghi, Mahlegha Damercheli

Published in: Comparative Clinical Pathology | Issue 3/2018

Login to get access

Abstract

Celiac disease is a genetic disease diagnosed to be associated with chronic intestinal inflammation. Endomysial and tissue transglutaminase antibodies are the best serum markers for celiac disease (CD) diagnosis. This research aimed to determine the levels of endomysial and tissue transglutaminase antibodies in patients with giardiasis. Forty cases of giardiasis were selected among the referees to Milad Hospital in Tehran, as well as a children’s hospital and some health centers in Karaj. Euro-immune IgA immunofluorescence and ELISA were utilized to measure their titers of endomysial and tissue transglutaminase antibodies, respectively. Twenty random serum samples of negative Giardia and 16 serum samples of positive anti-(tissue transglutaminase) tTG antibodies were evaluated by using ELISA and endomysium antibody through immunofluorescence techniques. Among the 40 cases of giardiasis, 16 positive endomysial and transglutaminase antibodies (40%) were detected. Sixteen positive samples of endomysial antibody (EMA) were also positive for anti-tTG, and 20 random negative samples were negative for EMA and anti-tTG. The chi-square test revealed a significant association between antibodies and giardiasis (P = 0.001). Atrophy of the intestinal villi can arise after giardia infection by mimicking the behavioral patterns of anti-EMA and anti-tTG antibodies. Due to low specificity, anti-gliadin antibody test is not helpful in detecting CD in patients with giardiasis. In the present study on anti-EMA and anti-tTG in patients with giardiasis, these antibodies were positive in giardiasis. Thus, the best and most reliable way to diagnose CD and treat giardiasis is intestinal biopsy as the gold standard method.
Literature
go back to reference Antonio C, Francesca C, Giuseppe M, Francesco P, Riccardo T, Giuseppe I (2001) Treatment of giardiasis reverses active coeliac disease to latent coeliac disease. Eur J Gastroenterol Hepatol 13(9):1101–1105CrossRef Antonio C, Francesca C, Giuseppe M, Francesco P, Riccardo T, Giuseppe I (2001) Treatment of giardiasis reverses active coeliac disease to latent coeliac disease. Eur J Gastroenterol Hepatol 13(9):1101–1105CrossRef
go back to reference Armstrong D, Don-Wauchope Andrew C, Verdu Elena F (2011) Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity. Can J Gastroenterol 25(4):193–197CrossRefPubMedPubMedCentral Armstrong D, Don-Wauchope Andrew C, Verdu Elena F (2011) Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity. Can J Gastroenterol 25(4):193–197CrossRefPubMedPubMedCentral
go back to reference Carroccio A, Cavataio F, Montalto G, Paparo F, Troncone R, Iacono G (2001) Treatment of giardiasis reverses “active” coeliac disease to “latent” coeliac disease. Eur J Gastroenterol Hepatol 13(9):1101–1105CrossRefPubMed Carroccio A, Cavataio F, Montalto G, Paparo F, Troncone R, Iacono G (2001) Treatment of giardiasis reverses “active” coeliac disease to “latent” coeliac disease. Eur J Gastroenterol Hepatol 13(9):1101–1105CrossRefPubMed
go back to reference Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman EG, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (2005) Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology. Hepatol Nutr J Pediatr Gastroenterol Nutr 40(1):1–19. https://doi.org/10.1097/00005176-200501000-00001 CrossRef Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman EG, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (2005) Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology. Hepatol Nutr J Pediatr Gastroenterol Nutr 40(1):1–19. https://​doi.​org/​10.​1097/​00005176-200501000-00001 CrossRef
go back to reference Sanders DS, Hurlstone DP, Stokes RO, Rashid F, Milford-Ward A, Hadjivassiliou M, Lobo AJ (2002) Changing face of adult coeliac disease: experience of a single university hospital in South Yorkshire. Postgrad Med J 78:31–33CrossRefPubMedPubMedCentral Sanders DS, Hurlstone DP, Stokes RO, Rashid F, Milford-Ward A, Hadjivassiliou M, Lobo AJ (2002) Changing face of adult coeliac disease: experience of a single university hospital in South Yorkshire. Postgrad Med J 78:31–33CrossRefPubMedPubMedCentral
go back to reference Sategna G, Solerio E, Scaglione N, Aimo G, Mengozzi G (2001) Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut 49(4):502–505CrossRefPubMedCentral Sategna G, Solerio E, Scaglione N, Aimo G, Mengozzi G (2001) Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut 49(4):502–505CrossRefPubMedCentral
go back to reference Swallow K, Wild G, Sargur R, Sanders DS, Aziz I, Hopper AD, Egner W (2013) Quality not quantity for transglutaminase antibody 2: the performance of an endomysial and tissue transglutaminase test in screening coeliac disease remains stable over time. Clin Exp Immunol 171(1):100–106CrossRefPubMed Swallow K, Wild G, Sargur R, Sanders DS, Aziz I, Hopper AD, Egner W (2013) Quality not quantity for transglutaminase antibody 2: the performance of an endomysial and tissue transglutaminase test in screening coeliac disease remains stable over time. Clin Exp Immunol 171(1):100–106CrossRefPubMed
Metadata
Title
Detecting endomysial and tissue transglutaminase antibodies in patients with giardiasis
Authors
Fateme Hajialiani
Fatemeh Tabatabaie
Lame Akhlaghi
Mahlegha Damercheli
Publication date
01-05-2018
Publisher
Springer London
Published in
Comparative Clinical Pathology / Issue 3/2018
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-018-2646-0

Other articles of this Issue 3/2018

Comparative Clinical Pathology 3/2018 Go to the issue